Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.148 EUR | -0.06% | +3.35% | +129.78% |
25/06 | Moberg Pharma Raises SEK336 Million from Share Sale | MT |
14/05 | Moberg Pharma AB Elects Jonas Ekblom as Board Member | CI |
Chart calendar Moberg Pharma AB
Upcoming events on Moberg Pharma AB
Past events on Moberg Pharma AB
03/06/2024 | BIO International Convention |
30/05/2024 | Redeye Growth Day |
16/05/2024 | Redeye Investor Forum |
14/05/2024 05:30 pm | Annual General Meeting |
07/05/2024 11:30 am | Q1 2024 Earnings Release |
07/05/2024 | Q1 2024 Earnings Call |
13/02/2024 12:30 pm | Q4 2023 Earnings Release |
13/02/2024 | Q4 2023 Earnings Call |
23/11/2023 03:50 pm | Redeye Life Science Day |
07/11/2023 12:30 pm | Q3 2023 Earnings Release |
07/11/2023 | Q3 2023 Earnings Call |
06/11/2023 | Bio-Europe Conference |
11/10/2023 | European Academy of Dermatology and Venereology Conference |
09/10/2023 01:00 pm | Extraordinary Shareholders Meeting |
31/08/2023 | Redeye Investor Forum |
11/08/2023 | Rights Issue: 16 new shares @ 5.75 SEK for 9 existing shares |
11/08/2023 | Rights Issue: 16 new shares @ 5.75 SEK for 9 existing shares |
08/08/2023 05:30 pm | Extraordinary Shareholders Meeting |
03/08/2023 11:30 am | Q2 2023 Earnings Release |
03/08/2023 | Q2 2023 Earnings Call |
Past dividends on Moberg Pharma AB
04/02/2021 | 0 SEK |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million SEK | Released Forecast Spread | 15,6 0,00 - | 50,5 | 0,00 | 0,21 21,0 -99.01% | 0,00 0,00 - | 6,00 |
EBITDA Million SEK | Released Forecast Spread | -3,00 -20,0 85% | 0,00 | -25,0 | -17,6 -17,0 -3.79% | -25,4 -29,0 12.54% | -36,0 |
EBIT Million SEK | Released Forecast Spread | -4,22 -20,0 78.9% | 0,00 | -29,0 | -20,2 -21,0 3.69% | -27,5 -32,0 14.18% | -37,0 |
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -5,07 -21,0 75.88% | 0,00 | 0,00 | 0,00 0,00 - | -25,4 -31,0 18% | -36,0 |
Net income Million SEK | Released Forecast Spread | 559 -21,0 2761.02% | 0,00 | 0,00 | -15,7 0,00 - | -21,1 -25,0 15.63% | -29,0 |
EPS SEK | Released Forecast Spread | 314 -12,0 2712.5% | 4,60 | 0,00 | -2,10 0,00 - | -1,33 -1,20 -10.83% | -7,00 |
Announcement Date | 27/09/19 | 09/02/21 | - | 07/02/23 | 13/02/24 | - |
Past sector events for Moberg Pharma AB
Today | GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected) |
16/07/2024 | CAMURUS AB: Q2 2024 Earnings Release |
11/07/2024 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
10/07/2024 | LOTUS PHARMACEUTICAL CO., LTD.: June 2024 Sales and Revenue Release |
09/07/2024 05:05 pm | SCINOPHARM TAIWAN, LTD.: June 2024 Sales and Revenue Release |
04/07/2024 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected) |
02/07/2024 02:35 pm | ONENESS BIOTECH CO., LTD.: June 2024 Sales and Revenue Release |
21/06/2024 08:58 pm | DEVA HOLDING: Q1 2024 Earnings Release |
14/06/2024 02:51 am | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
11/06/2024 11:00 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MOB Stock
- MB8 Stock
- Calendar Moberg Pharma AB